13/10/2017 09:54:16

Trinity Biotech plc to Announce 2017 Third Quarter Financial Results

DUBLIN, Ireland, Oct. 13, 2017 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report 2017 third quarter financial results on Thursday, October 26, 2017. The Company has scheduled a conference call for that same day, Thursday, October 26, 2017 at 11:00am ET (4:00pm BST) to discuss the results of the quarter.

Interested parties can access the call by dialing:

USA:1-844-861-5499
International:1-412-317-6581
Conference ID #:10113410

A simultaneous webcast of the call can be accessed at:

https://www.webcaster4.com/Webcast/Page/1135/23066

A replay of the call can be accessed until November 2, 2017 by dialing:

USA:1-877-344-7529
International:1-412-317-0088
Conference ID #:10113410

The webcast of the call will be available for 30 days at: 

https://www.webcaster4.com/Webcast/Page/1135/23066

Forward-looking statements in this release are made pursuant to the "safe harbor" provision of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties including, but not limited to, the results of research and development efforts, the effect of regulation by the United States Food and Drug Administration and other agencies, the impact of competitive products, product development commercialisation and technological difficulties, and other risks detailed in the Company's periodic reports filed with the Securities and Exchange Commission.

Trinity Biotech develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and to quantify the level of Haemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. Trinity Biotech sells direct in the United States, Germany, France and the U.K. and through a network of international distributors and strategic partners in over 75 countries worldwide. For further information please see the Company's website: www.trinitybiotech.com.

Contact

Kevin Tansley

Trinity Biotech plc

(353)-1-2769800

E-mail: kevin.tansley@trinitybiotech.com

Joe Diaz, Joe Dorame and Robert Blum

Lytham Partners, LLC

Investor Relations

602-889-9700

Primary Logo

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
15 Feb
PNDORA
  Jeg har gentagne gange analyseret Pandora. Læsere, som ønsker mine analyse af Pandoras forretnings..
80
10 Feb
I:SP500
Hejsa alle sammen   Så er det vinterferie og hvad kan tiden bruges til, ja lidt teknisk på stockmark..
36
13 Feb
 
Lad dog Henrik dø i fred i stedet for at komme med jeres dumsmarte bemærkninger   Det er upazsende u..
28
16 Feb
NOVO-B
@ Investor1 Jeg er hverken for eller imod hvad du skriver, men jeg har nu i gennem næsten et år løbe..
26
11 Feb
I:SP500
Prisdannelsen over S&P 500 med anvendelsen af candelstik med en månedlig tidsramme:   https://invst...
24
16 Feb
NOVO-B
Din og Investor1's totale fejlvurdering af både Zealand og Novo har desværre udviklet sig til et per..
19
15 Feb
OMXC20
Kære alle. Jeg har flere gange tilbudt at svare på investeringsspørgsmål for at bidrage til at så ma..
19
13 Feb
 
nu syntes jeg i er for åndsvage manden er ved at dø forhelvede
18
10 Feb
PNDORA
Jeg forstår ikke, hvordan man kan være så blæst i hovedet, som du er.
18
12 Feb
FING-B
Fjols
17

Elliott Capital Advisors, L.P : Form 8.3 - MELROSE INDUSTRIES PLC

16/02/2018 15:25:32
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Elliott Capital Advisors, L.P. (for itself and related general partners an..

Cisco Offers Cloud-Based Endpoint Security Solutions for Managed Security Service Providers

16/02/2018 13:00:19
Cisco's comprehensive cloud-based security endpoint portfolio provides advanced malware protection, internet security, and enterprise mobility management   SAN JOSE, Calif., Feb. 16, 2018 (GLOBE NEWSWIRE) -- Cisco today is helping address the challenges of Managed Security Service Providers (MSSP) and their customers by offering MSSPs comprehensive security, visibility, and control of cu..

Boussard & Gavaudan Investment Management LLP : Form 8.3 - UBM plc

16/02/2018 10:19:24
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a)  Identity of the person whose positions/dealings are being disclosed: Boussard & Gavaudan Investment Manage..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
PHOTO RELEASE--Huntington Ingalls Industries Awarded $1.43 Billion Contract For The Construction of LPD 29
2
Emerald Health, Strategic Majority Investor in Nemus Bioscience, Completes Final Closing of Private Placement Investment Ahead of Schedule
3
QUANTUM CORPORATION SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Quantum Corporation - QTM
4
WELLS FARGO SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Wells Fargo & Company - WFC
5
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Obalon Therapeutics, Inc. (OBLN)

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
17 February 2018 19:10:16
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180209.1 - EUROWEB4 - 2018-02-17 20:10:16 - 2018-02-17 19:10:16 - 1000 - Website: OKAY